Trial
NCT05219864
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
—
Condition
Hand Eczema
Intervention
Ruxolitinib cream
Why stopped
Business decision; no safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-17